Related Experiment Video

Updated: May 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem

Luigi Racioppi1

  • 1Department of Medicine, Duke University, Durham, NC 27707, USA. racioppi@unina.it

Trends in Molecular Medicine
|January 22, 2013
PubMed

Insights

Androgen receptor (AR) signaling drives prostate cancer (PC) and macrophage activation. Caulerpa taxifolia kinase 2 (CaMKK2) is a novel AR-regulated gene critical for PC progression and macrophage function, making it a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Androgen receptor (AR) signaling is crucial in sex hormone-regulated cancers, particularly prostate cancer (PC).
  • AR signaling influences cancer cell growth, survival, migration, and macrophage activation within the tumor microenvironment.
  • Macrophages play a pivotal role in the tumor ecosystem.

Purpose of the Study:

  • To investigate the role of Caulerpa taxifolia kinase 2 (CaMKK2) in prostate cancer and its relationship with androgen receptor signaling.
  • To determine if CaMKK2 is a critical regulator of macrophage activation in the context of prostate cancer.
  • To evaluate CaMKK2 as a potential therapeutic target for sex hormone-regulated cancers.

Main Methods:

  • Analysis of AR-regulated genes in prostate cancer.
  • Investigation of CaMKK2 expression and function in PC cells and macrophages.
  • Assessment of CaMKK2's role in macrophage activation pathways.

Main Results:

  • CaMKK2 is identified as a key AR-regulated gene in prostate cancer.
  • CaMKK2 is a critical regulator of macrophage activation.
  • CaMKK2 expression is significantly elevated in PC compared to normal prostate and immune cells.

Conclusions:

  • CaMKK2 acts as a molecular node integrating AR signaling and macrophage activation in prostate cancer.
  • CaMKK2 represents a promising novel therapeutic target for treating sex hormone-regulated malignancies like prostate cancer.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...